cancer « Science and Enterprise

Venture Firm, Cancer Center Start Antibody Biotech Company

By Alan, on September 6th, 2023%

A company formed by M.D. Anderson Cancer Center and Panacea Venture plans to develop synthetic antibodies as treatments addressing new cancer targets. . . . → Read More: Venture Firm, Cancer Center Start Antibody Biotech Company

Advanced Encryption Shown to Enable Cancer Data Sharing

By Alan, on August 15th, 2023%

Data scientists and cancer specialists demonstrate a data encryption technique that makes possible real-world cancer data sharing while preserving individual privacy. . . . → Read More: Advanced Encryption Shown to Enable Cancer Data Sharing

Trial Advances of Dual-Action Cancer Immunotherapy

By Alan, on August 3rd, 2023%

A clinical trial assessing a synthetic antibody to generate an immediate response and also generate a more durable treatment for solid tumor cancers, advanced to a mid-stage study. . . . → Read More: Trial Advances of Dual-Action Cancer Immunotherapy

Cancer Immunotherapy Biotech Issues $80M IPO

By Alan, on July 21st, 2023%

A biotechnology company designing immunotherapies for solid tumor cancers with a patient’s white blood cells is raising $80 million in its initial public offering or IPO. . . . → Read More: Cancer Immunotherapy Biotech Issues $80M IPO

Trial Underway Testing Engineered Cancer-Killing Viruses

By Alan, on July 18th, 2023%

A clinical trial, testing stem cells for neurons fortified with tumor-killing viruses, administered its first doses to a patient with glioma, an aggressive type of brain cancer. . . . → Read More: Trial Underway Testing Engineered Cancer-Killing Viruses

Crispr Therapy Shown to Reduce Harmful Gut Microbes

By Alan, on May 31st, 2023%

A clinical trial shows an oral therapy with engineered viruses delivers precise gene-edited payloads to reduce E. coli communities in the gut with no serious adverse effects. . . . → Read More: Crispr Therapy Shown to Reduce Harmful Gut Microbes

Precision T-Cell Solid Tumor Therapy Trial Underway

By Alan, on May 30th, 2023%

A clinical trial has begun testing a treatment for solid tumor cancers using engineered T-cells with proteins to attack specific tumor cells, but also avoid healthy cells. . . . → Read More: Precision T-Cell Solid Tumor Therapy Trial Underway

AI-Designed Cancer Vaccine Shown to Act Against Melanoma

By Alan, on May 26th, 2023%

Results of a small clinical trial show most patients with melanoma receiving a personalized therapeutic vaccine with an approved immunotherapy reduced at least some of their tumors. . . . → Read More: AI-Designed Cancer Vaccine Shown to Act Against Melanoma

Crispr Therapy Shown to Remove E. Coli in Gut

By Alan, on May 5th, 2023%

New research with lab animals shows gene-edited viruses can target and remove harmful E. coli bacteria from the gut, including strains usually resistant to antibiotics. . . . → Read More: Crispr Therapy Shown to Remove E. Coli in Gut

DNA Test Detects Early Bladder Cancer in Urine

By Alan, on May 2nd, 2023%

A genomic analysis of urine samples is shown to predict the most common form of bladder cancer years before symptoms appear. . . . → Read More: DNA Test Detects Early Bladder Cancer in Urine

Subscribe for email alerts

Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Like us on Facebook

Specials

Guest Posts

Please share Science & Enterprise